Product Program year 2025 Source: CMS Open Payments

Intera

Device Oncology

PDI 00850014110147

Open in the dashboard

General payments

$182,720

667 payments

Research payments

$0

0 payments

Through program year 2025, $182,720 in general payments and $0 in research payments were reported against Intera (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2025 General $91,774 354
2024 General $90,947 313

Breakdown

Who paid General payments · program years 2024–2025
  1. Intera Oncology, Inc $182,720 667 payments
Top recipients General payments · program year 2025
  1. Jason Castellanos Surgery · Philadelphia, PA $17,469 19% · 8 payments
  2. Chandrasekhar Padmanabhan Surgical Oncology · Nashville, TN $15,415 17% · 12 payments
  3. Louise Catherine Connell Medical Oncology · New York, NY $6,657 7% · 8 payments
  4. Jonathan Mizrahi Hematology & Oncology · Saint Louis, MO $6,202 7% · 4 payments
  5. Devika Rao Medical Oncology · Bronx, NY $3,750 4% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Surgical Oncology Surgery $26,184 30% · 60 practitioners
  2. Surgery $24,472 28% · 47 practitioners
  3. Medical Oncology Internal Medicine $13,736 16% · 18 practitioners
  4. Hematology & Oncology Internal Medicine $11,122 13% · 38 practitioners
  5. Nurse Practitioner, Family Nurse Practitioner $2,970 3% · 19 practitioners

The top 5 of 22 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. Pennsylvania $20,947 23% · 16 recipients
  2. Tennessee $17,210 19% · 17 recipients
  3. New York $14,410 16% · 22 recipients
  4. Missouri $8,012 9% · 11 recipients
  5. Texas $5,643 6% · 22 recipients

The top 5 of 32 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

667 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record